Data / Drug companies / Emtricitabine and tenofovir disoproxil fumarate
Emtricitabine and tenofovir disoproxil fumarate: 28 companies and 48 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Emtricitabine and tenofovir disoproxil fumarate is listed in the FDA National Drug Code Directory by 28 companies, with 48 products in commercial distribution. 43 of the products (89.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, and the newest product started marketing on July 1, 2025.
The request: Get every company that lists emtricitabine and tenofovir disoproxil fumarate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 28
- Products
- 48
- Generic (ANDA) products
- 43 (89.6%)
- Application numbers
- 12
- Routes
- Oral
- Brand names
- Truvada
- openFDA record search
- api.fda.gov
Companies that list emtricitabine and tenofovir disoproxil fumarate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Amneal Pharmaceuticals NY LLC | 4 | tablet, film coated | Generic drugs (ANDA) | August 26, 2018 |
| Gilead Sciences, Inc. | 4 | tablet, film coated | New drug applications (NDA) | March 10, 2016 |
| NuCare Pharmaceuticals,Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | March 9, 2022 |
| Zydus Lifesciences Limited | 4 | tablet, film coated | Generic drugs (ANDA) | July 1, 2021 |
| Zydus Pharmaceuticals USA Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | July 1, 2021 |
| A-S Medication Solutions | 3 | tablet, film coated | Generic drugs (ANDA) | March 9, 2022 |
| Aurobindo Pharma Limited | 3 | tablet, film coated | Generic drugs (ANDA) | March 9, 2023 |
| Cipla USA Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | November 1, 2021 |
| Amneal Pharmaceuticals NY LLC | 1 | tablet, film coated | Generic drugs (ANDA) | August 26, 2018 |
| Aurobindo Pharma Limited | 1 | tablet, film coated | Generic drugs (ANDA) | March 30, 2021 |
| AvKARE | 1 | tablet, film coated | Generic drugs (ANDA) | July 1, 2025 |
| Bryant Ranch Prepack | 1 | tablet, film coated | Generic drugs (ANDA) | July 26, 2019 |
| Camber Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | October 7, 2021 |
| Direct_Rx | 1 | tablet, film coated | Generic drugs (ANDA) | January 26, 2022 |
| Exelan Pharmaceuticals Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | April 6, 2021 |
| Golden State Medical Supply, Inc. | 1 | tablet | Generic drugs (ANDA) | January 13, 2021 |
| Laurus Labs Limited | 1 | tablet, film coated | Generic drugs (ANDA) | July 26, 2019 |
| Lupin Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | June 23, 2021 |
| Macleods Pharmaceuticals Limited | 1 | tablet, film coated | Generic drugs (ANDA) | May 15, 2020 |
| Major Pharmaceuticals | 1 | tablet, film coated | Generic drugs (ANDA) | July 26, 2019 |
| NorthStar Rx LLC | 1 | tablet, film coated | Generic drugs (ANDA) | March 9, 2022 |
| Proficient Rx LP | 1 | tablet, film coated | Generic drugs (ANDA) | October 7, 2021 |
| Proficient Rx LP | 1 | tablet, film coated | Generic drugs (ANDA) | March 30, 2021 |
| Quallent Pharmaceuticals Health LLC | 1 | tablet, film coated | Generic drugs (ANDA) | September 1, 2023 |
| Redpharm Drug | 1 | tablet, film coated | Generic drugs (ANDA) | October 7, 2021 |
| Strides Pharma Inc. | 1 | tablet | Generic drugs (ANDA) | March 30, 2021 |
| Strides Pharma Science Limited | 1 | tablet | Generic drugs (ANDA) | March 30, 2021 |
| Teva Pharmaceuticals USA, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | January 20, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 45 | 93.8% |
| Tablet | 3 | 6.2% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 43 | 89.6% |
| New drug applications (NDA) | 5 | 10.4% |
Pharmacologic classes
| Class | Products |
|---|---|
| Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor | 48 |
| Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor | 48 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.